Currently, neuropathological examination of the brain, neuroimaging, and biomarkers are widely accepted for the diagnosis of dementia, including the measurement of tau protein, phosphorylated tau protein, and Aβ 1–42, which requires the performance of an invasive procedure to collect cerebrospinal fluid, and can provide high diagnostic accuracy in diagnosis of dementia [34]. Here, MAPT is linked to dementia.